title: Aerosolized amiloride as treatment of cystic fibrosis lung disease: a pilot study.
authors.affiliation: University of North Carolina.
authors.forename: M R
authors.initials: MR
authors.lastname: Knowles
authors.forename: N L
authors.initials: NL
authors.lastname: Church
authors.forename: W E
authors.initials: WE
authors.lastname: Waltner
authors.forename: J R
authors.initials: JR
authors.lastname: Yankaskas
authors.forename: P
authors.initials: P
authors.lastname: Gilligan
authors.forename: M
authors.initials: M
authors.lastname: King
authors.forename: L J
authors.initials: LJ
authors.lastname: Edwards
authors.forename: R W
authors.initials: RW
authors.lastname: Helms
authors.forename: R C
authors.initials: RC
authors.lastname: Boucher
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000328:Adult; D000336:Aerosols; D000584:Amiloride / Q000008:administration & dosage*; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000503:physiopathology; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D013183:Sputum / Q000187:drug effects / Q000378:metabolism; D014797:Vital Capacity
chemical_list: D000336:Aerosols; D000584:Amiloride